| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243991 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusion: H-SRT with topotecan is feasible and well-tolerated in patients with recurrent high-grade glioma and results in similar survival compared with other repeat treatment modalities.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Reinhard E. M.D., David A. M.D., Lorenz M.D., Gesa M.D., Dirk M.D., Vivian P. Ph.D., Julia Ph.D., Christian M.D., Volker M.D.,